Navigation Links
Nectid Announces Initiation Of Clinical Development Of Autism And Pain Drugs
Date:8/16/2012

PRINCETON, N.J., Aug. 16, 2012 /PRNewswire/ -- Nectid, Inc. (www.nectid.com), a Princeton based pharmaceutical product development company focused on discovering and developing novel drugs, announced initiating clinical development of agomelatine for autism and pain indications in the United States.

Agomelatine is a melatonergic agonist (MT1 and MT2 receptors) and 5-HT2C antagonist and is approved for the treatment of major depressive disorder in Europe, Australia and in several countries. Agomelatine has been reported to resynchronize circadian rhythms to restore sleep cycle. Circadian rhythm is believed to be involved in several disorders such as neuropathic pain, fibromyalgia, inflammatory bowel disorders, autism spectrum disorders, and in multiple sclerosis.

Nectid's founder/CEO Ram Sesha has said, "This is a repurposing program of a known drug to provide several key unmet needs. Sleep and fatigue are significant issues in chronic pain and multiple sclerosis, etc.  Similarly, sleep difficulties particularly insomnia, occur in 50–80% of children with autism spectrum disorders and tend to affect day time behavior. In our proof of concept studies, Agomelatine was found effective in reducing neuropathic pain, pain from fibromyalgia, and in improving sleep and day time behavior in children with Autism Spectrum Disorders. The data, to be released soon, was found statistically significant in all three cases. Nectid plans to develop these projects through FDA approval while in licensing discussion with multiple interested parties." 

About Nectid

Nectid, (www.nectid.com), is a Princeton based drug-discovery company that focuses on repurposing known drugs for Central Nervous System (CNS), developmental and metabolic disorders. Nectid has licensed 21 patents in the last three years to branded pharmaceutical companies. Nectid raised a Series A funding recently from Singapore based Agnus Global Fund. Nectid has three project at clinical stage and six projects at conceptual stage. 


'/>"/>
SOURCE Nectid, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Apexigen Announces the Filing of an IND by its Partner, 3SBio
2. Neuralstem Announces Exercise Of Entire Over-Allotment Option By Aegis Capital Corp.
3. Perrigo Company Announces Quarterly Dividend
4. Trovagene, Inc. Announces Second Quarter and Year to Date Earnings, Provides Milestone Update
5. Cambrex Announces Significant New Supply Agreement
6. Sunpeaks Ventures Announces Second Quarter 2012 Results
7. MultiCell Announces Results of Shareholders Meeting
8. ChemAxon Announces New Version of chemicalize.org for Tablet PCs
9. Naturs Design Announces the Dreams With Hope Tour, a Nationwide Sleep Awareness Campaign
10. ADVENTRX Announces Appointment Of Chief Medical Officer
11. FDAnews Announces Medical Device Mobile Apps Virtual Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... -- Aptuit, LLC, hat heute den Beginn ... General Hospital (MGH) unter Leitung von Dr. Laurence ... und Validierung neuartiger Targets in gramnegativen Bakterien.  Aptuit erhofft ... Antibiotika bei der Behandlung schwerer Infektionen entgegenwirken können. ... ...
(Date:1/24/2017)... , Jan. 23, 2017 Laboratory Markets ... global use of mass spectrometry in both clinical and ... ,MS analysis, global market size of $6.8 billion and ... next four years, profiles the use of mass spectrometry ... 21 countries. This study investigated growth in the use ...
(Date:1/24/2017)... 2017 Global Market for Pharmaceutical ... A majority of medicines & drugs produced in ... (API), and such processes require alcoholic solvents such as ... of pharmaceutical solvents continues to be concentrated in the ... (APEJ) region as leading API suppliers and ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... 2017 , ... Element Blue ™, a leading IT ... partnership with Lucidworks , the company transforming the way people access information, ... building powerful enterprise search applications. , Element Blue is a global team of ...
(Date:1/24/2017)... MD (PRWEB) , ... January 24, 2017 , ... ... by MSC Cruises as part of the line’s 4th Annual MSC True Partnerships’ ... top performing North American travel partners for the year based on overall business growth ...
(Date:1/24/2017)... PLYMOUTH MEETING, PA (PRWEB) , ... January 24, ... ... clinical healthcare advocacy company, announced today that its annual Solutions Series of webinars ... will feature industry thought leaders discussing a number of current health and benefits ...
(Date:1/24/2017)... Santa Margarita, CA (PRWEB) , ... January 24, 2017 , ... ... advancement platform for 21st century leadership, has named Hector M. Chavez, Manager, Employee & ... and diabetes treatment center - as its Hispanic Leader of the Month. City of ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... to Thrive , Well-meaning studies such as the Fordham Institute’s High Stakes ... serve top students, such as including gifted or high-achieving students as a subgroup ...
Breaking Medicine News(10 mins):